22/04/2026
Most teams treat QA as an afterthought in healthcare AI products. That's expensive 💰
❌ Retrofitting compliance into a finished system costs 3–5x more and delays launch by months. And when PHI is involved, it's not just technical debt.
We built a full QA framework from scratch together with one of our clients, an AI-powered therapy documentation platform. No existing test infrastructure, non-deterministic AI outputs, HIPAA-compliant test environments required from day one.
Three things that actually work:
🟡 Testing AI output boundaries instead of exact content. Transcription and note generation aren't deterministic. You validate structure, required clinical sections, and response times, not identical strings.
🟡 Synthetic PHI is a compliance requirement, not a convenience. Real patient data in a test pipeline is a HIPAA violation regardless of intent.
🟡 BDD with Cucumber matters more in regulated products. Given/When/Then test cases are readable by compliance auditors and clinical reviewers, not just engineers.
🔥 Result: release testing went from several hours to 24 minutes. Automated regression detection on every build. QA stopped being the bottleneck.
Full case study on our blog, including the tech stack, environment architecture, and what breaks when you skip QA in medical AI products.
Link in the comments.